Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying robust biomarkers for the diagnosis and subtype distinction of inflammatory bowel disease through comprehensive serum metabolomic profiling

15 Feb 2025

Abstract excerpt

Inflammatory Bowel Disease (IBD), Crohn's disease (CD) and ulcerative colitis (UC), requires a combination of procedures and tests in diagnosis and discrimination. This study aimed to delineate specific serum metabolomic biomarkers that diagnose IBD and differentiate IBD subgroups. Serum samples and clinical metadata of the participants, IBD patients and Normal Controls (NC), were collected. Untargeted and...

Topics

Join the communities discussing this publication.

Gut microbiota and health
Inflammatory Bowel Disease
Microscopic Colitis

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39955397
DOI: 10.1038/s41598-025-90160-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying robust biomarkers for the diagnosis and subtype distinction of inflammatory bowel disease through comprehensive serum metabolomic profilingPMID 39955397Read ↗

Identifying Robust Biomarkers for the Diagnosis and Subtype Distinction of Inflammatory Bowel Disease through Comprehensive Serum Metabolomic ProfilingSemantic proximity Read ↗

Serum Metabolomics Identifies Altered Bioenergetics, Signaling Cascades in Parallel with Exposome Markers in Crohn’s DiseaseSemantic proximity Read ↗

A distinct serum metabolic signature outperforms C-reactive protein as a non-invasive marker for monitoring disease activity in Inflammatory Bowel DiseaseSemantic proximity Read ↗

Deciphering the microbiome–metabolome landscape of an inflammatory bowel disease inception cohortSemantic proximity Read ↗

Exploring the utility of metabolic profiling in stratifying patient groups in Inflammatory Bowel DiseaseSemantic proximity Read ↗

The faecal metabolome and its determinants in inflammatory bowel diseaseSemantic proximity Read ↗

Metabolomic analysis reveals key changes in amino acid metabolism in colorectal cancer patientsSemantic proximity Read ↗

Multi-omics phenotyping characterizes molecular divergence underlying different clinical scenarios of inflammatory bowel diseaseSemantic proximity Read ↗

Proteomics and metabolomics in inflammatory bowel disease.Semantic proximity Read ↗

Systematic Mining of gut microbiota biomarkers for IBDSemantic proximity Read ↗

Integrative Analysis of the Inflammatory Bowel Disease Serum Metabolome Improves Our Understanding of Genetic Etiology and Points to Novel Putative Therapeutic Targets.Semantic proximity Read ↗

Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohortsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.